Crossmark

The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study

Crossref DOI link: https://doi.org/10.1007/s00259-021-05383-3

Published Online: 2021-05-25

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmadzadehfar, Hojjat https://orcid.org/0000-0002-0393-5309
Matern, Ralf

Baum, Richard P.

Seifert, Robert

Kessel, Katharina

Bögemann, Martin

Kratochwil, Clemens

Rathke, Hendrik

Ilhan, Harun

Svirydenka, Hanna

Sathekge, Mike

Kabasakal, Levent

Yordanova, Anna

Garcia-Perez, Francisco Osvaldo

Kairemo, Kalevi

Maharaj, Masha

Paez, Diana

Virgolini, Irene

Rahbar, Kambiz
License Information

Text and Data Mining valid from 2021-05-25

Version of Record valid from 2021-05-25
More Information

Article History

Received: 13 December 2020

Accepted: 25 April 2021

First Online: 25 May 2021

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below